• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫西沙星在大鼠下颌骨及软组织中的渗透情况。

Penetration of moxifloxacin into rat mandibular bone and soft tissue.

作者信息

Cachovan Georg, Nergiz Ibrahim, Thuss Uwe, Siefert Hans-Martin, Sobottka Ingo, Oral Okhan, Platzer Ursula, Dogan-Onur Ozen

机构信息

Center of Oral and Dental Medicine, Department of Restorative and Preventive Dentistry, University of Hamburg, Hamburg, Germany.

出版信息

Acta Odontol Scand. 2009;67(3):182-6. doi: 10.1080/00016350902787564.

DOI:10.1080/00016350902787564
PMID:19306136
Abstract

OBJECTIVE

Based on its in vitro activity and spectrum of activity, the new 8-methoxyquinolone antibiotic moxifloxacin (MXF) seems suited for the antibiotic therapy of odontogenic infections. Penetration into the relevant tissue is another prerequisite for clinical efficacy. For this reason, the levels of MXF in plasma, soft tissue, and mandibular bone were determined in an animal model with Wistar rats.

MATERIAL AND METHODS

Samples of 49 rats were analyzed. Tissue samples were homogenized and proteins were precipitated. The pharmacokinetic evaluation was conducted based on non-compartmental analysis.

RESULTS

The concentration-time courses of tissues show a more plateau-shaped curve compared to plasma. Calculated AUC (area under the curve) ratios tissue:plasma were M. masseter:plasma = 2.64 and mandibles:plasma = 1.13.

CONCLUSIONS

Administration of antibiotics is considered an important part of therapy during and/or after surgical procedures in the maxillofacial area. Because of the good penetration into bone and muscle tissues demonstrated in Wistar rats, MXF might be an option for clinical application in this indication.

摘要

目的

基于其体外活性和活性谱,新型8-甲氧基喹诺酮类抗生素莫西沙星(MXF)似乎适用于牙源性感染的抗生素治疗。渗透到相关组织中是临床疗效的另一个先决条件。因此,在Wistar大鼠动物模型中测定了血浆、软组织和下颌骨中的MXF水平。

材料与方法

分析了49只大鼠的样本。将组织样本匀浆并沉淀蛋白质。基于非房室分析进行药代动力学评估。

结果

与血浆相比,组织的浓度-时间曲线呈现出更平缓的形状。计算得出的组织:血浆AUC(曲线下面积)比值为:咬肌:血浆 = 2.64,下颌骨:血浆 = 1.13。

结论

在颌面部手术期间和/或术后,抗生素给药被认为是治疗的重要组成部分。由于在Wistar大鼠中显示出对骨和肌肉组织的良好渗透性,MXF可能是该适应症临床应用的一个选择。

相似文献

1
Penetration of moxifloxacin into rat mandibular bone and soft tissue.莫西沙星在大鼠下颌骨及软组织中的渗透情况。
Acta Odontol Scand. 2009;67(3):182-6. doi: 10.1080/00016350902787564.
2
Penetration of moxifloxacin into liver tissue.莫西沙星向肝组织的渗透。
Int J Antimicrob Agents. 2012 Jun;39(6):505-9. doi: 10.1016/j.ijantimicag.2012.01.022. Epub 2012 Apr 21.
3
Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.单次静脉注射或口服莫西沙星后其在人体胰腺中的渗透情况。
J Antimicrob Chemother. 2006 Nov;58(5):994-9. doi: 10.1093/jac/dkl353. Epub 2006 Sep 6.
4
Moxifloxacin penetration into human gastrointestinal tissues.莫西沙星在人体胃肠道组织中的渗透情况。
J Antimicrob Chemother. 2004 May;53(5):875-7. doi: 10.1093/jac/dkh173. Epub 2004 Mar 31.
5
High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.高剂量左氧氟沙星与莫西沙星治疗葡萄球菌实验性异物感染的对比:较高的与最低抑菌浓度相关的药代动力学参数对疗效的影响。
J Infect. 2009 Mar;58(3):220-6. doi: 10.1016/j.jinf.2009.01.005. Epub 2009 Feb 12.
6
Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.莫西沙星对泌乳山羊肌内注射后的药代动力学及在乳汁中的渗透情况
Vet J. 2007 Mar;173(2):452-5. doi: 10.1016/j.tvjl.2005.11.003. Epub 2005 Dec 27.
7
Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.莫西沙星在腹膜炎中的药代动力学及腹膜穿透性
J Antimicrob Chemother. 2006 Sep;58(3):693-6. doi: 10.1093/jac/dkl305.
8
Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.莫西沙星在接受常规体外循环手术患者胸骨中的渗透情况。
Int J Antimicrob Agents. 2006 Nov;28(5):428-32. doi: 10.1016/j.ijantimicag.2006.08.019. Epub 2006 Oct 10.
9
Disposition kinetics of moxifloxacin in lactating ewes.莫西沙星在泌乳母羊体内的处置动力学。
Vet J. 2008 Nov;178(2):282-7. doi: 10.1016/j.tvjl.2007.08.007. Epub 2007 Sep 27.
10
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.莫西沙星在病态肥胖患者血浆和组织中的药代动力学。
J Antimicrob Chemother. 2011 Oct;66(10):2330-5. doi: 10.1093/jac/dkr282. Epub 2011 Jul 5.

引用本文的文献

1
Clinical and Microbiological Efficacy of Adjunctive Systemic Quinolones to Mechanical Therapy in Periodontitis: A Systematic Review of the Literature.全身应用喹诺酮类药物辅助机械治疗牙周炎的临床及微生物学疗效:文献系统评价
Int J Dent. 2022 May 21;2022:4334269. doi: 10.1155/2022/4334269. eCollection 2022.
2
A multilevel analysis of a randomized clinical trial comparing adjunctive moxifloxacin versus amoxicillin/metronidazole for the treatment of aggressive periodontitis.一项随机临床试验的多水平分析,比较辅助使用莫西沙星与阿莫西林/甲硝唑治疗侵袭性牙周炎的效果。
Dent Res J (Isfahan). 2021 Jun 22;18:44. eCollection 2021.
3
Is the penetration of clindamycin into the masseter muscle really enough to treat odontogenic infections?
克林霉素渗入咬肌的程度真的足以治疗牙源性感染吗?
Clin Oral Investig. 2021 May;25(5):3257-3266. doi: 10.1007/s00784-020-03656-z. Epub 2020 Oct 31.
4
Moxifloxacin versus Clindamycin/Ceftriaxone in the management of odontogenic maxillofacial infectious processes: A preliminary, intrahospital, controlled clinical trial.莫西沙星与克林霉素/头孢曲松在牙源性颌面感染性疾病治疗中的对比:一项初步的、医院内对照临床试验
J Clin Exp Dent. 2015 Dec 1;7(5):e634-9. doi: 10.4317/jced.52627. eCollection 2015 Dec.
5
Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis.全身应用莫西沙星与阿莫西林/甲硝唑辅助非手术治疗广泛侵袭性牙周炎的比较
Med Oral Patol Oral Cir Bucal. 2015 Jul 1;20(4):e441-9. doi: 10.4317/medoral.20552.
6
Microbiological analysis of a prospective, randomized, double-blind trial comparing moxifloxacin and clindamycin in the treatment of odontogenic infiltrates and abscesses.一项前瞻性、随机、双盲临床试验的微生物分析,比较莫西沙星和克林霉素治疗牙源性浸润和脓肿的效果。
Antimicrob Agents Chemother. 2012 May;56(5):2565-9. doi: 10.1128/AAC.06428-11. Epub 2012 Feb 21.
7
Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.莫西沙星与克林霉素治疗牙源性脓肿和炎症浸润的疗效和安全性比较:一项 II 期、双盲、随机试验。
Antimicrob Agents Chemother. 2011 Mar;55(3):1142-7. doi: 10.1128/AAC.01267-10. Epub 2010 Dec 20.